# Study of Nasonex® for the Treatment of Nasal Polyps in Pediatric Subjects Between Ages of 6 and Less Than 18 Years Old (P04292)

> **NCT00378378** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 127 (actual)

## Conditions studied

- Nasal Polyps

## Interventions

- **DRUG:** Mometasone Furoate Nasal Spray (MFNS)
- **DRUG:** Placebo nasal spray

## Key facts

- **NCT ID:** NCT00378378
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 127 (ACTUAL)
- **Last updated:** 2024-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00378378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00378378, "Study of Nasonex® for the Treatment of Nasal Polyps in Pediatric Subjects Between Ages of 6 and Less Than 18 Years Old (P04292)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00378378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*